Oncology Research Hub

Explore cutting-edge studies in tumor biology, molecular pathways, and clinical breakthroughs

Research Articles

The Molecular Case: Why Gleason 6 Prostate Cancer Still Deserves the "Cancer" Label

Exploring the molecular evidence supporting the cancer designation for Gleason 6 prostate cancer through proteomic, genomic, and transcriptomic analysis.

Jonathan Peterson
Nov 01, 2025

Popular Articles